We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock

Delisted

SEEL was delisted on the 15th of October, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$12.2M +$10.3M +5 +500%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.4M
HVC
3
Healthcare Value Capital
New Jersey
$935K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$471K
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$315K
BFA
6
BlackRock Fund Advisors
California
$217K
Northern Trust
7
Northern Trust
Illinois
$169K
Bank of New York Mellon
8
Bank of New York Mellon
New York
$118K
CC
9
Callan Capital
California
$104K
BIP
10
Brandes Investment Partners
California
$100K
Franklin Resources
11
Franklin Resources
California
$98K
RCM
12
Rotella Capital Management
Washington
$79K
HighTower Advisors
13
HighTower Advisors
Illinois
$73K
Millennium Management
14
Millennium Management
New York
$54K
Bank of America
15
Bank of America
North Carolina
$50K
EEG
16
E.E. Geduld
$47K
Morgan Stanley
17
Morgan Stanley
New York
$35K
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$35K
BA
19
BlackRock Advisors
Delaware
$31K
FANJ
20
Financial Architects (New Jersey)
New Jersey
$19K
State Street
21
State Street
Massachusetts
$19K
BIM
22
BlackRock Investment Management
Delaware
$12K
AIG
23
American International Group
New York
$11.5K
Creative Planning
24
Creative Planning
Kansas
$11K
Group One Trading
25
Group One Trading
Illinois
$11K